Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

16:52 IST BSE
Board Meeting OutcomeBCC Fuba India Ltd BCCFUBA

BCC Fuba India Board Meeting Outcome

BCC Fuba India Limited approved a First and Final Call of ₹37.50 per share on 45,93,015 partly paid-up shares, totaling ₹17.22 Crore. The board also approved a reallocation of ₹1.16 Crore in Rights Issue proceeds towards new machinery due to geopolitical factors and cost efficiencies. The call payment period is May 25 to June 08, 2026.

Value
₹17.22 Cr
16:50 IST NSE
Legal & RegulatoryNidan Laboratories And Healthcare Ltd NIDAN

Nidan Laboratories And Healthcare Legal & Regulatory

Nidan Laboratories and Healthcare Limited received a SEBI Show Cause Notice alleging mis-utilization of ₹29.99 Crore from its ₹50 Crore IPO proceeds. The regulator is investigating deviations from prospectus disclosures during FY 2021-2024. The financial impact is currently undetermined as proceedings are at the notice stage.

Value
₹29.99 Cr
16:46 IST BSE
Annual General MeetingDeccan Gold Mines Ltd DECNGOLD

Deccan Gold Mines Annual General Meeting

Deccan Gold Mines Limited has convened an EGM on May 21, 2026, to approve material related party transactions totaling ₹170 Crore. These include loans and guarantees for subsidiaries in Dubai and Kyrgyzstan to develop gold projects. This meeting aims to secure necessary shareholder consent for these significant financial arrangements.

Value
₹170.0 Cr
Execution
Financial Year 2026-2027
16:44 IST NSE
Management ChangePiramal Pharma Ltd PPLPHARMA

Piramal Pharma Management Change

Piramal Pharma Limited announced a leadership overhaul, appointing Maneesh Sharma as Company Secretary and Compliance Officer, effective April 29, 2026. The board also approved the re-appointment of Nandini Piramal and Peter DeYoung as Executive Directors, alongside Independent Directors Sridhar Gorthi and Peter Stevenson. These changes ensure long-term governance stability and executive continuity.

Execution
36-60 months